
Lupin Limited has informed the Exchange regarding a press release dated February 09, 2023, titled "Lupin Receives Approval from U.S. FDA for Glycopyrrolate Injection, USP.".
Filed with NSE ·
Watch Lupin's latest callLupin (NSE:LUPIN) Q2 2027 Earnings Call · Replay · Nov 4Read the transcript of Lupin (NSE:LUPIN) Q2 2027 Earnings Call
Lupin Limited has informed the Exchange regarding a press release dated February 09, 2023, titled "Lupin Receives Approval from U.S. FDA for Glycopyrrolate Injection, USP.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin